chicago personal injury lawyer

The FDA announced on February 19, 2008 that Actavis Inc. is certain Fentyl transdermal patches. These patches may be defective causing an excess amount of medication to be administered to the patient. This overdose of medication can lead to respiratory depression and possible fatal overdose.